The Festival of Genomics, Biodata & AI returns to Boston at a critical moment for the US life sciences community. Funding pressures, rising development costs and intensifying competition are colliding with an unprecedented opportunity: the convergence of multi-omics, large-scale biodata and artificial intelligence.

To stay ahead, organizations must do more than generate data - they must integrate technologies, break down silos and translate insight into measurable progress, in research, drug discovery and translation into the clinic.

Bringing together 2,500+ professionals from pharma, biotech, healthcare, research and emerging tech, the Festival is designed to help you do exactly that. Across eight theatres, 180+ expert speakers and with the help of data-rich case studies, you’ll explore the very latest in how you can leverage omics, AI and advanced analytics to transform drug discovery, accelerate development, further your research projects and enable precision medicine.

View the event here.